Vaxart, Inc. Revenue Breakdown
No Revenue Breakdown for VXRT on this site yet.
- 2025-12-31: Others Not split by product in the filing$237.26M100.00%; Total revenue $237.26M.
- 2024-12-31: Others Not split by product in the filing$28.70M100.00%; Total revenue $28.70M.
- 2023-12-31: Others Not split by product in the filing$7.38M100.00%; Total revenue $7.38M.
- 2018-12-31: Others Not split by product in the filing$4.16M100.00%; Total revenue $4.16M.
Source checked: the stored Revenue Breakdown page for VXRT.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $237.26M 100.00% | $237.26M |
| 2024-12-31 | Not split by product in the filing $28.70M 100.00% | $28.70M |
| 2023-12-31 | Not split by product in the filing $7.38M 100.00% | $7.38M |
| 2018-12-31 | Not split by product in the filing $4.16M 100.00% | $4.16M |
| 2017-12-31 | Not split by product in the filing $5.84M 100.00% | $5.84M |
| 2017-06-30 | Not split by product in the filing $8.90M 100.00% | $8.90M |
| 2016-06-30 | Not split by product in the filing $9.30M 100.00% | $9.30M |
| 2015-06-30 | Not split by product in the filing $24.60M 100.00% | $24.60M |
| 2014-06-30 | Not split by product in the filing $68.70M 100.00% | $68.70M |
| 2013-06-30 | Not split by product in the filing $33.60M 100.00% | $33.60M |
| 2012-06-30 | Not split by product in the filing $20.40M 100.00% | $20.40M |
| 2011-12-31 | Not split by product in the filing $14.84M 100.00% | $14.84M |
| 2011-06-30 | Not split by product in the filing $12.50M 100.00% | $12.50M |
| 2010-12-25 | Not split by product in the filing $35.01M 100.00% | $35.01M |
| 2009-12-26 | Not split by product in the filing $10.49M 100.00% | $10.49M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $27.18M 100.00% | $27.18M |
| 2026-03-31 | Not split by product $39.23M 100.00% | $39.23M |
| 2025-12-31 | Not split by product $104.24M 100.00% | $104.24M |
| 2025-09-30 | Not split by product $72.41M 100.00% | $72.41M |
| 2025-06-30 | Not split by product $39.73M 100.00% | $39.73M |
| 2025-03-31 | Not split by product $20.88M 100.00% | $20.88M |
| 2024-12-31 | Not split by product $15.19M 100.00% | $15.19M |
| 2024-09-30 | Not split by product $4.93M 100.00% | $4.93M |
| 2024-06-30 | Not split by product $6.40M 100.00% | $6.40M |
| 2024-03-31 | Not split by product $2.18M 100.00% | $2.18M |
| 2023-12-31 | Not split by product $3.25M 100.00% | $3.25M |
| 2023-09-30 | Not split by product $2.10M 100.00% | $2.10M |
| 2023-06-30 | Not split by product $1.36M 100.00% | $1.36M |
| 2023-03-31 | Not split by product $675.00K 100.00% | $675.00K |
| 2019-03-31 | Not split by product $5.41M 100.00% | $5.41M |
| 2018-12-31 | Not split by product $1.77M 100.00% | $1.77M |
| 2018-09-30 | Not split by product $281.00K 100.00% | $281.00K |
| 2018-06-30 | Not split by product $608.00K 100.00% | $608.00K |
| 2018-03-31 | Not split by product $1.50M 100.00% | $1.50M |
| 2017-12-31 | Not split by product $760.00K 100.00% | $760.00K |
| 2017-09-30 | Not split by product $915.00K 100.00% | $915.00K |
| 2017-06-30 | Not split by product $1.85M 100.00% | $1.85M |
| 2017-03-31 | Not split by product $2.31M 100.00% | $2.31M |
| 2016-12-31 | Not split by product $3.80M 100.00% | $3.80M |
| 2016-09-30 | Not split by product $100.00K 100.00% | $100.00K |
| 2016-06-30 | Not split by product $600.00K 100.00% | $600.00K |
| 2016-03-31 | Not split by product $5.30M 100.00% | $5.30M |
| 2015-12-31 | Not split by product $1.70M 100.00% | $1.70M |
| 2015-09-30 | Not split by product $1.70M 100.00% | $1.70M |
| 2015-06-30 | Not split by product $4.10M 100.00% | $4.10M |
| 2015-03-31 | Not split by product $5.90M 100.00% | $5.90M |
| 2014-12-31 | Not split by product $13.90M 100.00% | $13.90M |
| 2014-09-30 | Not split by product $700.00K 100.00% | $700.00K |
| 2014-06-30 | Not split by product $8.50M 100.00% | $8.50M |
| 2014-03-31 | Not split by product $29.50M 100.00% | $29.50M |
| 2013-12-31 | Not split by product $18.50M 100.00% | $18.50M |
| 2013-09-30 | Not split by product $12.20M 100.00% | $12.20M |
| 2013-06-30 | Not split by product $9.30M 100.00% | $9.30M |
| 2013-03-31 | Not split by product $12.50M 100.00% | $12.50M |
| 2012-12-31 | Not split by product $10.40M 100.00% | $10.40M |
| 2012-09-30 | Not split by product $1.40M 100.00% | $1.40M |
| 2012-06-30 | Not split by product $631.00K 100.00% | $631.00K |
| 2012-03-31 | Not split by product $7.09M 100.00% | $7.09M |
| 2011-12-31 | Not split by product $2.09M 100.00% | $2.09M |
| 2011-09-24 | Not split by product $1.09M 100.00% | $1.09M |
| 2011-06-25 | Not split by product $3.74M 100.00% | $3.74M |
| 2011-03-26 | Not split by product $9.17M 100.00% | $9.17M |
| 2010-12-25 | Not split by product $4.08M 100.00% | $4.08M |
| 2010-09-25 | Not split by product $12.34M 100.00% | $12.34M |
| 2010-06-26 | Not split by product $4.85M 100.00% | $4.85M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |